home / stock / agio / agio articles

AGIO Articles, Agios Pharmaceuticals Inc. - From 05/14/24

Stock Information
Company Name: Agios Pharmaceuticals Inc.
Stock Symbol: AGIO
Market: NASDAQ
Website: agios.com
Menu
AGIO AGIO Quote AGIO Short AGIO News AGIO Articles AGIO Message Board
Get AGIO Alerts

News, Short Squeeze, Breakout and More Instantly...
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress | Benzinga

– Data from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia to be Presented in Plenary Session – – Additional P...
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024 | Benzinga

CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and PK activation ...

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024 | Benzinga

CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and PK activation ...

Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024 | Benzinga

CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and PK activatio...
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024 | Benzinga

CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism pion...

Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024 | Benzinga

CAMBRIDGE, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism pion...

Why Is Blood Disorder Focused Agios Pharmaceuticals Stock Trading Higher Today? | Benzinga

Agios Pharmaceuticals Inc (NASDAQ: AGIO) says the Phase 3 ENERGIZE study of mitapivat in adults with non-transfusion-dependent (NTD) alpha- or...
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024 | Benzinga

CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism pion...

Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorders at 65th ASH Annual Meeting and Exposition | Benzinga

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Dis...

Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023 | Benzinga

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism pion...
Previous 10 Next 10